Galenic formulation for colon-targeted delivery of active...

Details Galenic formulation for colon-targeted delivery of active... Galenic formulation for colon-targeted delivery of active...

2008-12-29

2010-11-16

Tate, Christopher R (Department: 1651)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

C424S093100, C424S094100, C424S094300, C424S094600, C424S423000, C427S002210, C435S197000, C435S231000, C536S002000

Reexamination Certificate

active

07833765

ABSTRACT:
The invention concerns multiparticulate galenic formulations for oral administration and designed for colon targeted delivery of active principles selected from the group comprising enzymes capable of inactivating macrolides and the like, enzymes capable of inactivating quinolones and β-lactamases.

REFERENCES:
patent: 3959457 (1976-05-01), Speaker et al.
patent: 5607671 (1997-03-01), Heino
patent: 6436461 (2002-08-01), Bouwmeesters et al.
patent: 6500423 (2002-12-01), Olshenitsky et al.
patent: 6531152 (2003-03-01), Lerner et al.
patent: 6632451 (2003-10-01), Penhasi et al.
patent: 7018629 (2006-03-01), Jacob et al.
patent: 2004/0067223 (2004-04-01), Jacob et al.
patent: 0 213 303 (1987-03-01), None
patent: 0 273 823 (1988-07-01), None
patent: 0 338 499 (1989-10-01), None
patent: 0 454 044 (1991-10-01), None
patent: 0 480 729 (1992-04-01), None
patent: 04-013724 (1992-01-01), None
patent: 8807865 (1988-10-01), None
patent: 9200732 (1992-01-01), None
patent: 9313757 (1993-07-01), None
patent: 9313795 (1993-07-01), None
patent: 9505939 (1995-03-01), None
patent: 9727843 (1997-08-01), None
patent: 9815192 (1998-04-01), None
Arthur, M., et al., “Heterogeneity of genes conferring high-level resistance to erythromycin by inactivation in enterobacteria(Abstract Only)”, “Annales de L'Institut Pasteur, Microbiologie”, Jan./Feb. 1986, pp. 125-134, vol. 137, No. 1.1.
Aydin, Zuhal, et al., “Preparation and evaluation of pectin beads”, “International Journal of Pharmaceutics”, 1996, pp. 133-136, vol. 137.
Krishnaiah, Y. S. R., et al., “Evaluation of guar gum as a compression coat for drug targeting to colon”, “International Journal of Pharmaceutics”, 1998, pp. 137-146, vol. 171.
Leonard, F., et al., “Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization”, “J. Infectious Disease (CAS Abstract)”, 1989, pp. 274-280, vol. 160, No. 2.
Mathiowitz, E., et al., “Oral drug delivery, small intestine & colon”, “Encyclopedia of Controlled Drug Delivery”, 1999, pp. 717-728, vol. 1-2.
Milojevic, Snezana, et al., “Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid . . . ”, “Journal of Controlled Release”, 1996, pp. 75-84, vol. 38.
Munjeri, O., et al., “Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug . . . ”, “Journal of Controlled Release”, 1997, pp. 273-278, vol. 46.
Munjeri, O., et al., “An investigation into the suitability of amidated pectin hydrogel beads as a delivery matrix for chloroquine”, “Journal of Pharmaceutical Sciences”, Aug. 1998, pp. 905-908, vol. 87, No. 8.
Noguchi, Norihisa, et al., “Regulation of transcription of the mph(A) gene for macrolide 2′-phosphotransferase I inEschericha coli: . . . ”, “Journal of Bacteriology”, Sep. 2000, pp. 5052-5058, vol. 182, No. 18.
Ounissi, Houria, et al., “Nucleotide sequence of the gene ereA encoding the erythromycin esterase inEscherichia coli(Abstract Only)”, “Gene”, 1985, pp. 271-278, vol. 35, No. 3.
Rubinstein, Abraham, et al., “Colonic drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content”, “Pharmaceutical Research”, 1992, pp. 276-278, vol. 9, No. 2.
Rubinstein, Abraham, et al., “In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier”, “Pharmaceutical Research”, 1993, pp. 258-263, vol. 10, No. 2.
Sriamornsak, Pornsak, “Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads”, “International Journal of Pharmaceutics”, 1998, pp. 213-220, vol. 169.
Sriamornsak, Pornsak, “Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins . . . ”, “European Journal of Pharmaceutical Sciences”, 1999, pp. 221-227, vol. 8.
Wakerly, Z., et al., “Pectin/ethylcellulose film coating formulations for colonic drug delivery”, “Pharmaceutical Research”, 1996, pp. 1210-1212, vol. 13, No. 8.
Liu, P., et al., “Alginate-Pectin-Poly-L-Lysine Particualte as a Potential Controlled Release Formulation”, “Journal of Pharm. Pharmacology”, pp. 141-149, vol. 51; Abstract Only.

Affiliated with

Also associated with

Rating

Galenic formulation for colon-targeted delivery of active... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenic formulation for colon-targeted delivery of active..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic formulation for colon-targeted delivery of active... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4229536